MedCity News

JULY 5, 2023

Providers often have a checklist of requirements they use to determine whether they should bring new technology into their organization. Digital health startups would be wise to learn about these criteria when taking their products to market, said Meg Barron, the AMA’s vice president of digital health strategy, at a recent conference. That way, startups can build their products around meeting providers’ needs.

Marketing 122

Marketing Medical 122

Fierce Pharma

JULY 6, 2023

After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. | After becoming chairman of the powerful Senate Health, Education, Labor and Pensions Committee earlier this year, Sen. Bernie Sanders, I-Vermont—a longtime opponent of Big Pharma—has become even more ubiquitous in his efforts to reduce drug prices.

Education 363

Education Government Pharma 363

Pharmaceutical Technology

JULY 4, 2023

Substance use disorders leave people with long-term negative mental and physical health implications and can lead to death.

Leads 130

Leads 130

David Bagga

JULY 3, 2023

Building your career as a salesperson in the medical field requires great planning. Here are some tips to boost your efforts. When it comes to the medical sales career, Medical Device Sales Career Home Blog How to Build Your Career as a Medical… How to Build Your Career as a Medical Sales Person? Building your […] The post How to Build Your Career as a Medical Sales Person?

Medical sales 130

Medical sales Medical Sales Medical sales reps 130

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

MedCity News

JULY 7, 2023

An Epic Research study found that 16 out of 24 specialties had higher follow-up rates within 90 days of an initial office visit than a telehealth visit. This includes mental health, physical medicine and rehabilitation and pain medicine, which all had a more than 20% higher follow-up rate after an in-person office appointment than a telehealth appointment.

Leads 135

Leads Medicine 135

Fierce Pharma

JULY 6, 2023

Less than two months into its "Pivot to Growth" strategy under a new CEO, Israeli-American generics giant Teva Pharmaceutical could be weighing a major shake-up of its key drug ingredients business | Teva is looking at strategic options for its active pharmaceutical ingredient unit, with a potential sale on the table, BNN Bloomberg and Benzinga have reported.

Sales 357

Sales Pharmaceutical 357

Pharmaceutical Technology

JULY 3, 2023

Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.

119

119

MedCity News

JULY 6, 2023

Two VCs from Merck Global Health Innovation Fund recently offered fundraising advice for digital health companies. They told these firms to expect slower funding timelines, urged them not to be afraid of down or flat rounds, and advised them to spend time nailing down the specifics of their growth narrative.

124

124

Fierce Pharma

JULY 7, 2023

As demand skyrockets for GLP-1 drugs that can trigger significant weight loss, unauthorized versions of the treatments have started to fill pharmacies. | In late May, the FDA warned of illegal knockoffs of Novo Nordisk’s Ozempic and Wegovy. And now, the Danish company has filed its second wave of lawsuits against pharmacies in the U.S. that are producing the copycats.

FDA 325

FDA 325

European Pharmaceutical Review

JULY 4, 2023

The International Organization for Standardization (ISO) has published its new standard Sterilization of health care products — Microbiological methods — Part 3 Bacterial endotoxin testing ( ISO 11737-3:2023). The document contains requirements and guidance for testing for bacterial endotoxins. This includes products that must be non-pyrogenic based on either intended use or non-pyrogenic label claim, or both.

Manufacturing 111

Manufacturing Medicine Pharmaceutical 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

JULY 4, 2023

While drug shortages have been a major cause for concern over the past few years, medications to treat cancer are in particularly short supply.

Medical 111

Medical 111

MedCity News

JULY 4, 2023

A new cohort of startups has graduated from PharmStars, a digital health accelerator. This latest group focused on women’s health and health equity.

Biopharma 124

Biopharma Pharma 124

Fierce Pharma

JULY 5, 2023

Despite political tensions between Washington and Beijing, foreign pharmaceutical investments are progressing in China. | In a deal that could be worth up to $1 billion, Massachusetts-based Moderna inked a memorandum of understanding, plus a land collaboration agreement, to research, develop and manufacture mRNA medicines in China.

Manufacturing 299

Manufacturing Medicine Pharmaceutical 299

PharmExec

JULY 5, 2023

Rose Blackburne, MD, MBA, vice president, global head, general medicine, PPD Clinical Research, Thermo Fisher Scientific, discusses health equity in pharma, specifically racial biases, and how the industry can address inequities in access and care going forward.

Pharma 105

Pharma Medicine 105

Advertisement

Pharmaceutical Technology

JULY 6, 2023

Lifera, Arabio and Sanofi have signed a memorandum of understanding (MOU) to bolster manufacturing of vaccines in Saudi Arabia.

Manufacturing 111

Manufacturing 111

MedCity News

JULY 3, 2023

An AstraZeneca and Daiichi Sankyo cancer drug achieved one of the main goals of a Phase 3 study in non-small cell lung cancer. But patient deaths were also reported in the study, and the companies disclosed few details about them.

Patients 121

Patients Biopharma Pharma 121

Fierce Pharma

JULY 6, 2023

It’s official: Roughly half a year after the FDA granted an accelerated nod to Eisai and Biogen’s new Alzheimer’s disease med lecanemab, the companies have converted that green light into a full-fl | With a full approval in hand, Leqembi has become the first treatment shown to reduce the rate of disease progression and slow cognitive and functional decline in adults with Alzheimer’s disease under the FDA's traditional approval pathway.

FDA 290

FDA 290

European Pharmaceutical Review

JULY 3, 2023

The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products. US drug product quality: drug recalls in FY2022 During the 2022 financial year, 166 manufacturing sites generated 912 drug recalls, the highest number of recalls in five years, according to the data.

Food and Drug Administration 105

Food and Drug Administration FDA Manufacturing Product sample 105

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharmaceutical Technology

JULY 5, 2023

Following FDA approival and CE marking for Incyte’s JAK-inhibiting cream Opzelura (ruxolitinib), the MHRA has followed suit in the UK.

FDA 105

FDA 105

MedCity News

JULY 2, 2023

CellTrans’s Lantidra is now the first FDA-approved cell therapy for type 1 diabetes. The therapy is made from islet cells sourced from deceased donors.

FDA 119

FDA Biopharma Pharma 119

Fierce Pharma

JULY 6, 2023

GSK’s Cabenuva made history in 2020 as the world’s firs | GSK's long-acting Cabenuva is currently approved only as a switch therapy for patients who already have undetectable HIV levels in the blood. Trying to reach some tough populations who have difficulty adhering to existing daily oral therapies, GSK is getting creative.

Patients 278

Patients 278

European Pharmaceutical Review

JULY 7, 2023

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Competition 104

Competition Biopharma Government Manufacturing 104

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

JULY 4, 2023

Abeona Therapeutics has raised $25m from its current select investors to launch and commercialise its cell therapy, EB-101.

105

105

MedCity News

JULY 2, 2023

New research predicts that healthcare costs will increase by 7% next year. The estimate is higher than the projected medical cost trends in 2022 and 2023 — which were 5.5% and 6.0%, respectively.

Medical 119

Medical Healthcare Healthcare 119

Fierce Pharma

JULY 6, 2023

During the first earnings call Brent Saunders led since his return at Bausch + Lomb, the CEO laid out what he believes is the company’s biggest issue: underutilization of existing infrastructure. | During the first earnings call Brent Saunders led since his return at Bausch + Lomb, the CEO laid out what he believes is the company’s biggest issue: underutilization of existing infrastructure.

274

274

Copyright Clearance Center

JULY 7, 2023

According to PW’s Andrew Albanese, the ALA conference highlighted an organized response from the library and publishing communities to politicized attacks on the freedom to read.

98

98

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

Pharmaceutical Technology

JULY 3, 2023

2023 started with a buzz around ChatGPT, and more generally around the immense potential that generative AI (GenAI) holds.

105

105

MedCity News

JULY 5, 2023

Insurtechs like Bright Health Group, Clover Health and Oscar Health set out to disrupt health insurance — but have they actually done so? Not in a positive way, several experts say.

Insurance 116

Insurance 116

Fierce Pharma

JULY 7, 2023

AstraZeneca and Daiichi Sankyo's TROP2 antibody-drug conjugate returned a concerning safety message. Moderna reportedly plans to invest up to $1 billion in China. | AstraZeneca and Daiichi Sankyo delivered a concerning safety message for their TROP2 antibody-drug conjugate. Moderna reportedly plans to invest up to $1 billion in China. Takeda expanded its antibody partnership with F-Star Therapeutics with a new deal potentially worth $1 billion.

Safety 264

Safety Pharma 264

PharmaVoice

JULY 7, 2023

Leqembi’s U.S. approval is a milestone in Alzheimer’s research and medicine — and there are a few other late-stage biologic drugs that could follow.

Medicine 98

Medicine 98

Advertisement

Distribution